Edition:
India

Mersana Therapeutics announces pricing of initial public offering

June 27 (Reuters) - Mersana Therapeutics Inc ::Mersana Therapeutics announces pricing of initial public offering.Says initial public offering of 5.00 million common shares priced at $15.00 per share.

4:37am IST

Amgen receives positive CHMP opinion to expand use of mimpara

June 23 (Reuters) - Amgen Inc ::Amgen receives positive CHMP opinion to expand use of mimpara (cinacalcet) for the treatment of secondary hyperparathyroidism in certain children with end-stage renal disease on dialysis.Amgen Inc - CHMP positive opinion will now be reviewed by European Commission.

Saturday, 24 Jun 2017

Celsion cancels registered direct offering

June 22 (Reuters) - Celsion Corp ::Celsion Corporation announces cancellation of registered direct offering.Company noted it did not possess ability to register a sufficient number of shares pursuant to form S-3 until July 1, 2017.Company has entered into an agreement with each of investors to...

Friday, 23 Jun 2017

Suda signs MOU to acquire anti-cancer agent

June 20 (Reuters) - Suda Ltd ::Suda signs term sheet to acquire Novel Oro- Mucosal anti-cancer agent.Signed a binding memorandum of understanding (mou) with UK-based Aluztra Bio Ltd.Under terms of MOU, Suda has up to six months to complete its due diligence on Anagrelide before entering a definitive...

Tuesday, 20 Jun 2017

Markets

  • Sectors
  • Asia
  • U.S.
  • Europe

Sector Summary

Upcoming Events

No related earnings announcements are currently scheduled within the next 7 days.